Product Program year 2024 Source: CMS Open Payments

Xulane

Drug Contraceptives, Transdermal

NDC 0378-3340-32

Open in the dashboard

General payments

$96,745

4,997 payments

Research payments

$4,271,330

425 payments

Through program year 2024, $96,745 in general payments and $4,271,330 in research payments were reported against Xulane (Contraceptives, Transdermal).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2024 General $3,857 2
2022 General $90,223 4,994
2022 Research $4,237,956 422
2021 General $2,665 1
2021 Research $33,374 3

Breakdown

Who paid General payments · program years 2021–2024
  1. Mylan Pharmaceuticals Inc. $92,854 4,993 payments
  2. Mylan Inc. $3,857 2 payments
  3. Mylan Specialty L.P. $35 2 payments
Top recipients General payments · program year 2024
  1. Jeffrey Jensen Obstetrics & Gynecology · Portland, OR $2,204 57% · 1 payment
  2. Andrew Kaunitz Obstetrics & Gynecology · Jacksonville, FL $1,653 43% · 1 payment

Each share is of general payments naming this product in 2024.

Specialties paid General payments · program year 2024
  1. Obstetrics & Gynecology $3,857 100% · 2 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2024
  1. Oregon $2,204 57% · 1 recipient
  2. Florida $1,653 43% · 1 recipient

Each share is of general payments naming this product in 2024 where a state was reported.

Prescribed to Medicare patients

Part D · data year 2024

Part D claims

623

Prescriptions dispensed, refills included

Drug cost

$57,653

Paid at the pharmacy, in all

Prescribers

49

With 11 or more claims of it

Medicare Part D drugs matched to Xulane, 2024
Part D drug Name match Relative to the largest Prescribers Claims Drug cost
Xulane Norelgestromin/Ethin.Estradiol Same name 49 623 $57,653

Matched to this product by name; CMS does not link its files to Open Payments, so a similar name can be a different strength, form or brand. Prescriber counts include only prescribers with 11 or more claims of the drug, because CMS publishes nothing below that. Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy; it does not include drugs given in a clinic or hospital, or patients with other insurance.

Largest prescribers

First 5 of 49 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Austin Atkins Physician Assistant TX 17 $1,116 None on record
Chasady Freeze Nurse Practitioner OH 16 $2,028 None on record
Mario Martinez Family Practice CA 16 $997 None on record
Christopher Broadway Family Practice TX 15 $1,993 None on record
Frank Ling Obstetrics & Gynecology TN 15 $1,607 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 49 with Patron
4,997 general · 425 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record